Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Beam Therapeutics Inc. , founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm.

52W Range

60thpctl

Volume

0.62×avg

Market Cap

3.02BUSD

P/E Ratio

-35.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Beam Therapeutics Inc.

BEAMNASDAQ Global Select·USD·Closed

Beam Therapeutics Inc.

BEAMNASDAQ·USD·Closed

$29.32

−3.81%

$29.32

−$1.16 (3.81%)

52W Range

60thpctl

Volume

0.62×avg

Mkt Cap

3.02BUSD

P/E

-35.8TTM

Div Yield

–ann

BEAM: Beam Therapeutics Inc. Stock Analysis | finqOS